Zaremba, A.; Jansen, P.; Murali, R.; Mayakonda, A.; Riedel, A.; Krahl, D.; Burkhardt, H.; John, S.; Géraud, C.; Philip, M.;
et al. Genetic and Methylation Analysis of CTNNB1 in Benign and Malignant Melanocytic Lesions. Cancers 2022, 14, 4066.
https://doi.org/10.3390/cancers14174066
AMA Style
Zaremba A, Jansen P, Murali R, Mayakonda A, Riedel A, Krahl D, Burkhardt H, John S, Géraud C, Philip M,
et al. Genetic and Methylation Analysis of CTNNB1 in Benign and Malignant Melanocytic Lesions. Cancers. 2022; 14(17):4066.
https://doi.org/10.3390/cancers14174066
Chicago/Turabian Style
Zaremba, Anne, Philipp Jansen, Rajmohan Murali, Anand Mayakonda, Anna Riedel, Dieter Krahl, Hans Burkhardt, Stefan John, Cyrill Géraud, Manuel Philip,
and et al. 2022. "Genetic and Methylation Analysis of CTNNB1 in Benign and Malignant Melanocytic Lesions" Cancers 14, no. 17: 4066.
https://doi.org/10.3390/cancers14174066
APA Style
Zaremba, A., Jansen, P., Murali, R., Mayakonda, A., Riedel, A., Krahl, D., Burkhardt, H., John, S., Géraud, C., Philip, M., Kretz, J., Möller, I., Stadtler, N., Sucker, A., Paschen, A., Ugurel, S., Zimmer, L., Livingstone, E., Horn, S.,
... Griewank, K.
(2022). Genetic and Methylation Analysis of CTNNB1 in Benign and Malignant Melanocytic Lesions. Cancers, 14(17), 4066.
https://doi.org/10.3390/cancers14174066